A comparison of sotagliflozin therapy for diabetes mellitus between week 24 with week 52

Background: According to the centers for disease control and prevention, 14% of American adults have diabetes – 10% know it, and more than 4% go undiagnosed. Sotagliflozin is a new type of diabetes drug This study is to compare the efficacy of Sotagliflozin therapy for Diabetes Mellitus (DM) between week 24 with week 52. Methods and analysis: Through to October 2019, Web of Science, PubMed Database, Cochrane Library, EMBASE, Clinical Trials and...